EAGLE PHARMACEUTICALS INC's ticker is EGRX and the CUSIP is 269796108. A total of 170 filers reported holding EAGLE PHARMACEUTICALS INC in Q4 2017. The put-call ratio across all filers is 0.73 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $21,000 | +23.5% | 425 | 0.0% | 0.00% | +100.0% |
| Q4 2018 | $17,000 | -71.2% | 425 | -50.1% | 0.00% | -75.0% |
| Q3 2018 | $59,000 | -15.7% | 852 | -7.9% | 0.00% | -20.0% |
| Q2 2018 | $70,000 | +34.6% | 925 | -7.3% | 0.01% | +66.7% |
| Q1 2018 | $52,000 | -96.8% | 998 | -96.7% | 0.00% | -96.3% |
| Q4 2017 | $1,618,000 | -10.3% | 30,289 | +0.2% | 0.08% | +10.8% |
| Q3 2017 | $1,803,000 | +30.8% | 30,233 | +73.1% | 0.07% | +42.3% |
| Q2 2017 | $1,378,000 | – | 17,465 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Park West Asset Management LLC | 1,120,235 | $53,749,000 | 2.66% |
| TANG CAPITAL MANAGEMENT LLC | 255,616 | $12,264,000 | 1.19% |
| Smith, Graham & Co., Investment Advisors, LP | 158,671 | $7,613,000 | 0.92% |
| ARMISTICE CAPITAL, LLC | 282,000 | $13,530,000 | 0.59% |
| Capital Impact Advisors, LLC | 35,815 | $1,718,000 | 0.57% |
| Matarin Capital Management, LLC | 58,977 | $2,830,000 | 0.56% |
| GLOBEFLEX CAPITAL L P | 31,702 | $1,521,000 | 0.39% |
| CHARTWELL INVESTMENT PARTNERS, LLC | 200,246 | $9,608,000 | 0.37% |
| Stanley-Laman Group, Ltd. | 24,000 | $1,152,000 | 0.28% |
| VIRTUS ALTERNATIVE INVESTMENT ADVISERS, INC. | 264 | $13,000 | 0.20% |